Abstract
Prostaglandin E2 produced endogenously (by cyclooxygenases) can regulate macrophage phagocytosis. Cyclooxygenase activity reduction (mainly through inhibition of inducible Cox-2) can induce PGE2 synthesis depression and can activate the phagocytosis process. There are no reports in the literature explaining whether conjugated linoleic acid dienes (trans-10, cis-12 CLA and cis-9, trans-11 CLA) modify the phagocytic activity of human macrophages. For the purpose of this study, monocytes were isolated from venous blood, incubated for 7 days with 30 μM CLAs, and then (in some experiments) LPS (1 μg/mL) was added to the medium. Subsequently, monocyte/macrophage phagocytosis, NF-κB transcription factor activity, Cox-2 and PPARγ mRNA expression (and the amounts of Cox-2 and PPARγ proteins) and PGE2 synthesis were determined. Both CLA isomers increased macrophage phagocytosis through inhibition of Cox-2 expression (might by inactivation the NF-κB pathway). The inhibition of mRNA Cox-2 expression contributed (particularly with respect to trans-10, cis-12 CLA) to a decrease in protein Cox-2 synthesis and to reduction of prostaglandin E2 content in the cell. The inhibition of PGE2 synthesis (by CLA treatment) enhanced the phagocytosis process in macrophages.
Similar content being viewed by others
Abbreviations
- CLA:
-
Conjugated linoleic acid
- Cox:
-
Cyclooxygenase
- LPS:
-
Lipopolysaccharide
- NF-κB:
-
Nuclear factor κB
- PPAR:
-
Peroxysome proliferator activated receptors
- PGE2 :
-
Prostaglandin E2
References
Paoletti R, Poli A, Cignarella A (2006) The emerging link between nutrition, inflammation and atherosclerosis. Expert Rev Cardiovasc Ther 4:385–393
de Pablo MA, Alvarez de Cienfuegos G (2000) Modulatory effects of dietary lipids on immune system functions. Immunol Cell Biol 78:31–39
Fritsche K (2006) Fatty acids as modulators of the immune response. Annu Rev Nutr 26:45–73
Calder PC (2006) n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83:1505S–1519S
Sampath H, Ntambi JM (2004) Polyunsaturated fatty acid regulation of gene expression. Nutr Rev 62:333–339
Ramakers JD, Plat J, Sebedio JL, Mensink RP (2005) Effects of the individual isomers cis-9, trans-11 vs. trans-10, cis-12 of conjugated linoleic acid (CLA) on inflammation parameters in moderately overweight subjects with LDL-phenotype B. Lipids 40:909–918
Schleser S, Ringseis R, Eder K (2005) Conjugated linoleic acids have no effect on TNF alpha-induced adhesion molecule expression, U937 monocyte adhesion, and chemokine release in human aortic endothelial cells. Atherosclerosis 186:337–344
Zhang H, Guo Y, Yuan J (2005) Conjugated linoleic acid enhanced the immune function in broiler chicks. Br J Nutr 94:746–752
Toomey S, Harhen B, Roche HM, Fitzgerald D, Belton O (2006) Profound resolution of early atherosclerosis with conjugated linoleic acid. Atherosclerosis 187:40–49
Torres-Duarte AP, Vanderhoek JY (2003) Conjugated linoleic acid exhibits stimulatory and inhibitory effects on prostanoid production in human endothelial cells and platelets. Biochim Biophys Acta 1640:69–76
Banni S, Petroni A, Blasevich M, Carta G, Cordeddu L, Murru E, Melis MP, Mahon A, Belury MA (2004) Conjugated linoleic acids (CLA) as precursors of a distinct family of PUFA. Lipids 39:1143–1146
Turpeinen AM, Mutanen M, Aro A, Salminen I, Basu S, Palmquist DL, Griinari JM (2002) Bioconversion of vaccenic acid to conjugated linoleic acid in humans. Am J Clin Nutr 76:504–510
Burdge GC, Lupoli B, Russell JJ, Tricon S, Kew S, Banerjee T, Shingfield KJ, Beever DE, Grimble RF, Williams CM, Yaqoob P, Calder PC (2004) Incorporation of cis-9, trans-11 or trans-10, cis-12 conjugated linoleic acid into plasma and cellular lipids in healthy men. J Lipid Res 45:736–741
Zulet MA, Marti A, Parra MD, Martinez JA (2005) Inflammation and conjugated linoleic acid: mechanisms of action and implications for human health. J Physiol Biochem 61:483–494
Yu Y, Correll PH, Van den Heuvel JP (2002) Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism. Biochim Biophys Acta 1581:89–99
Ecker J, Langmann T, Moehle C, Schmitz G (2007) Isomer specific effects of conjugated linoleic acid on macrophage ABCG1 transcription by a SREBP-1c dependent mechanism. Biochem Biophys Res Commun 352:805–811
Llaverias G, Lacasa D, Vinals M, Vazquez-Carrera M, Sanchez RM, Laguna JC, Alegret M (2004) Reduction of intracellular cholesterol accumulation in THP-1 macrophages by a combination of rosiglitazone and atorvastatin. Biochem Pharmacol 68:155–163
Houseknecht KL, Vanden Heuvel JP, Moya-Camarena SY, Portocarrero CP, Peck LW, Nickel KP, Belury MA (1998) Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun 244:678–682
Taylor CG, Zahradka P (2004) Dietary conjugated linoleic acid and insulin sensitivity and resistance in rodent models. Am J Clin Nutr 79:1164S–1168S
Wang YW, Jones PJ (2004) Conjugated linoleic acid and obesity control: efficacy and mechanisms. Int J Obes Relat Metab Disord 28:941–955
Pariza MW, Park Y, Cook ME (1999) Conjugated linoleic acid and the control of cancer and obesity. Toxicol Sci 52:107–110
Kew S, Banerjee T, Minihane AM, Finnegan YE, Williams CM, Calder PC (2003) Relation between the fatty acid composition of peripheral blood mononuclear cells and measures of immune cell function in healthy, free-living subjects aged 25–72 y. Am J Clin Nutr 77:1278–1286
Kang JH, Lee GS, Jeung EB, Yang MP (2007) Trans-10, cis-12-conjugated linoleic acid increases phagocytosis of porcine peripheral blood polymorphonuclear cells in vitro. Br J Nutr 97:117–125
Kanters E, Pasparakis M, Gijbels MJ, Vergouwe MN, Partouns-Hendriks I, Fijneman RJ, Clausen BE, Forster I, Kockx MM, Rajewsky K, Kraal G, Hofker MH, de Winther MP (2003) Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin Invest 112:1176–1185
Collins T, Cybulsky MI (2001) NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 107:255–264
Bureau F, Vanderplasschen A, Jaspar F, Minner F, Pastoret PP, Merville MP, Bours V, Lekeux P (2002) Constitutive nuclear factor-kappaB activity preserves homeostasis of quiescent mature lymphocytes and granulocytes by controlling the expression of distinct Bcl-2 family proteins. Blood 99:3683–3691
Jeremias I, Kupatt C, Baumann B, Herr I, Wirth T, Debatin KM (1998) Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells. Blood 91:4624–4631
Piret B, Piette J (1996) Topoisomerase poisons activate the transcription factor NF-kappaB in ACH-2 and CEM cells. Nucleic Acids Res 24:4242–4248
Schoonbroodt S, Piette J (2000) Oxidative stress interference with the nuclear factor-kappa B activation pathways. Biochem Pharmacol 60:1075–1083
Bours V, Bentires-Alj M, Hellin AC, Viatour P, Robe P, Delhalle S, Benoit V, Merville MP (2000) Nuclear factor-kappa B, cancer, and apoptosis. Biochem Pharmacol 60:1085–1089
Webster GA, Perkins ND (1999) Transcriptional cross talk between NF-kappaB and p53. Mol Cell Biol 19:3485–3495
Poligone B, Baldwin AS (2001) Positive and negative regulation of NF-kappaB by COX-2: roles of different prostaglandins. J Biol Chem 276:38658–38664
Zhao GP, Zhou ZG, Lei WZ, Yu YY, Zheng XL, Gao HK (2005) Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells. Biochem Biophys Res Commun 336:909–917
Pontsler AV, St Hilaire A, Marathe GK, Zimmerman GA, McIntyre TM (2002) Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein. J Biol Chem 277:13029–13036
Inoue H, Tanabe T, Umesono K (2000) Feedback control of cyclooxygenase-2 expression through PPARgamma. J Biol Chem 275:28028–28032
Evans M, Geigerman C, Cook J, Curtis L, Kuebler B, McIntosh M (2000) Conjugated linoleic acid suppresses triglyceride accumulation and induces apoptosis in 3T3-L1 preadipocytes. Lipids 35:899–910
Meadus WJ, MacInnis R, Dugan ME (2002) Prolonged dietary treatment with conjugated linoleic acid stimulates porcine muscle peroxisome proliferator activated receptor gamma and glutamine-fructose aminotransferase gene expression in vivo. J Mol Endocrinol 28:79–86
Belury MA, Moya-Camarena SY, Lu M, Shi L, Leesnitzer LM, Blanchard SG (2002) Conjugated linoleic acid is an activator and ligand for peroxisome proliferator-activated receptor-gamma (PPARγ). Nutr Res 22:817–824
Tilley SL, Coffman TM, Koller BH (2001) Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 108:15–23
Takashiba S, Van Dyke TE, Amar S, Murayama Y, Soskolne AW, Shapira L (1999) Differentiation of monocytes to macrophages primes cells for lipopolysaccharide stimulation via accumulation of cytoplasmic nuclear factor kappaB. Infect Immun 67:5573–5578
Aronoff DM, Canetti C, Petrs-Golden M (2004) Prostaglandin E 2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. Immunol 173:559–565
Kang JH, Kim JH, Chung CS, Lee CY, Yang MP (2004) Immunoenhancing effects of conjugated linoleic acid on phagocytosis activity of porcine peripheral blood phagocytes. J Vet Clin 21:336–342
Kang KB, Van Der Zypp A, Iannazzo L, Majewski H (2006) Age-related changes in monocyte and platelet cyclooxygenase expression in healthy male humans and rats. Transl Res 148:289–94
Eligini S, Colli S, Basso F, Sironi L, Tremoli E (1999) Oxidized low density lipoprotein suppresses expression of inducible cyclooxygenase in human macrophages. Arterioscler Thromb Vasc Biol 19:1719–1725
Evans M, Park Y. Patiza M, Curtis L, Kuebler B, McIntish M (2001) Trans-10, cis-12 conjugated linoleic acid reduces triglyceride content while differentially affecting peroxisome proliferator activated receptor gamma2 and aP2 expression in 3T3-L1 preadipocytes. Lipids 36:1223–1232
Umino T, Skold CM, Pirruccello SJ, Spurzem JR, Rennard SI (1999) Two-colour flow-cytometric analysis of pulmonary alveolar macrophages from smokers. Eur Respir J 13:894–899
Marx N, Sukhova G, Murphy C, Libby P, Plutzky J (1998) Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. Am J Pathol 153:17–23
Zapolska-Downar D, Siennicka A, Kaczmarczyk M, Kolodziej B, Naruszewicz M (2004) Butyrate inhibits cytokine-induced VCAM-1 and ICAM-1 expression in cultured endothelial cells: the role of NF-kappaB and PPARalpha. J Nutr Biochem 15:220–228
Dembinska-Kiec A, Polus A, Kiec-Wilk B, Grzybowska J, Mikolajczyk M, Hartwich J, Razny U, Szumilas K, Banas A, Bodzioch M, Stachura J, Dyduch G, Laidler P, Zagajewski J, Langman T, Schmitz G (2005) Proangiogenic activity of beta-carotene is coupled with the activation of endothelial cell chemotaxis. Biochim Biophys Acta 1740:222–239
Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
Eligini S, Stella Barbieri S, Cavalca V, Camera M, Brambilla M, De Franceschi M, Tremoli E, Colli S (2005) Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-alpha and phorbol ester in human endothelial cells. Cardiovasc Res 65:683–693
Li G, Dong B, Butz DE, Park Y, Pariza MW, Cook ME (2006) NF-kappaB independent inhibition of lipopolysaccharide-induced cyclooxygenase by a conjugated linoleic acid cognate, conjugated nonadecadienoic acid. Biochim Biophys Acta 1761:969–72
Li G, Barnes D, Butz D, Bjorling D, Cook ME (2005) 10t, 12c-conjugated linoleic acid inhibits lipopolysaccharide-induced cyclooxygenase expression in vitro and in vivo. J Lipid Res 46:2134–42
Wang LS, Huang YW, Liu S, Chang HL, Ye W, Shu S, Sugimoto Y, Funk JA, Smeaks DD, Hill LN, Lin YC (2006) Conjugated linoleic acid (CLA) modulates prostaglandin E2 (PGE2) signaling in canine mammary cells. Anticancer Res 26:889–98
De Caterina R, Spiecker M, Solaini G, Basta G, Bosetti F, Libby P, Liao J (1999) The inhibition of endothelial activation by unsaturated fatty acids. Lipids 34:S191–S204
Cheng WL, Lii CK, Chen HW, Lin TH, Liu KL (2004) Contribution of conjugated linoleic acid to the suppression of inflammatory responses through the regulation of the NF-kappaB pathway. J Agric Food Chem 52:71–78
Inoue H, Tanabe T, Umesono K (2000) Feedback control of cyclooxygenase-2 expression through PPARgamma. J Biol Chem 275:28028–28032
Fukushima M (1992) Biological activities and mechanisms of action of PGJ2 and related compounds: an update. Prostaglandins Leukot Essent Fatty Acids 47:1–12
Hwang DM, Kundu JK, Shin JW, Lee JC, Lee HJ, Surh YJ (2007) cis-9, trans-11-conjugated linoleic acid down-regulates phorbol ester-induced NF-kappaB activation and subsequent COX-2 expression in hairless mouse skin by targeting IkappaB kinase and PI3K-Akt. Carcinogenesis 28:363–371
Zambon A, Gervois P, Pauletto P, Fruchart JC, Staels B (2006) Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence. Arterioscler Thromb Vasc Biol 26:977–986
Acknowledgments
Supported by grant no. 3PO5B 11723 from the State Committee for Scientific Research, Poland. M. Baśkiewicz-Masiuk is a scholarship holder of the Foundation for Polish Science.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Stachowska, E., Baśkiewicz-Masiuk, M., Dziedziejko, V. et al. Conjugated Linoleic Acids Can Change Phagocytosis of Human Monocytes/Macrophages by Reduction in Cox-2 Expression. Lipids 42, 707–716 (2007). https://doi.org/10.1007/s11745-007-3072-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11745-007-3072-2